384 related articles for article (PubMed ID: 26075713)
1. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
[TBL] [Abstract][Full Text] [Related]
2. Role of patient-, tumor- and systemic inflammatory response-related factors in predicting survival of patients with node-negative gastric cancer.
Qu J; Qu X; Li Z; Zhang J; Teng Y; Jin B; Zhao M; Yu P; Wang Z; Liu Y
Tumour Biol; 2017 Jun; 39(6):1010428317698374. PubMed ID: 28618960
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
7. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
9. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
[TBL] [Abstract][Full Text] [Related]
10. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
[TBL] [Abstract][Full Text] [Related]
11. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
[TBL] [Abstract][Full Text] [Related]
12. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
13. Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?
Liu Y; Chen XH; Meng XH; Liu CF; Zhao LL; Han JW; Zhuang LW
Hepatogastroenterology; 2012; 59(114):623-6. PubMed ID: 22024039
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases.
Liu C; Zhang R; Lu Y; Li H; Lu P; Yao F; Jin F; Xu H; Wang S; Chen J
Surg Oncol; 2010 Mar; 19(1):4-10. PubMed ID: 19042124
[TBL] [Abstract][Full Text] [Related]
15. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
[TBL] [Abstract][Full Text] [Related]
16. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
17. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy.
Lu J; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX
Surg Oncol; 2013 Sep; 22(3):167-71. PubMed ID: 23787074
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognosis of Borrmann type IV gastric cancer.
Zhu YL; Yang L; Sui ZQ; Liu L; Du JF
J BUON; 2016; 21(6):1471-1475. PubMed ID: 28039710
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
